HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Christopher S Cooper Selected Research

Diurnal Enuresis (Daytime Wetting)

5/2007Initial trial of timed voiding is warranted for all children with daytime incontinence.
10/2006Improved efficacy of extended release oxybutynin in children with persistent daytime urinary incontinence converted from regular oxybutynin.
5/2006Frequency of wetting is predictive of response to anticholinergic treatment in children with overactive bladder.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Christopher S Cooper Research Topics

Disease

13Vesico-Ureteral Reflux (Vesicoureteral Reflux)
11/2021 - 04/2003
6Urinary Tract Infections (Urinary Tract Infection)
01/2021 - 10/2004
4Hydronephrosis
10/2021 - 04/2002
3Urinary Incontinence
05/2007 - 01/2003
3Diurnal Enuresis (Daytime Wetting)
05/2007 - 05/2006
2Pyelonephritis
01/2020 - 09/2009
2Overactive Urinary Bladder (Overactive Bladder)
11/2007 - 05/2006
2Constipation
05/2006 - 10/2003
1Ataxia (Dyssynergia)
10/2017
1Obesity
08/2017
1Dementia (Dementias)
08/2017
1Muscle Weakness
12/2016
1Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker)
12/2016
1Weight Gain
07/2011
1Cicatrix (Scar)
09/2009
1Neurogenic Urinary Bladder (Bladder, Neurogenic)
09/2006
1Infections
10/2004
1Pain (Aches)
08/2003
1Atrophy
07/2003
1Meningomyelocele (Myelomeningocele)
01/2003
1Ureterocele
05/2002

Drug/Important Bio-Agent (IBA)

6Anti-Bacterial Agents (Antibiotics)IBA
01/2021 - 08/2006
5Cholinergic Antagonists (Anticholinergics)IBA
10/2017 - 05/2006
3glutaraldehyde-cross-linked collagenIBA
05/2007 - 01/2003
2dextranomerIBA
11/2021 - 06/2012
2defluxIBA
11/2021 - 06/2012
2oxybutynin (Tavor)FDA LinkGeneric
10/2006 - 05/2006
1Hyaluronic Acid (Hyaluronan)IBA
11/2021
1DiureticsIBA
10/2021
1Indicators and Reagents (Reagents)IBA
01/2020
1Anesthetics (Anesthetic Agents)IBA
08/2017
1DystrophinIBA
12/2016
1dextranomer-hyaluronic acid copolymerIBA
06/2012
1salicylhydroxamic acid (SHAM)IBA
07/2011
1PowdersIBA
10/2003
1polyethylene glycol 3350 (miralax)FDA LinkGeneric
10/2003
1LubricantsIBA
08/2003
1Lidocaine (Xylocaine)FDA LinkGeneric
08/2003
1CreatinineIBA
04/2003
1CollagenIBA
01/2003

Therapy/Procedure

5Antibiotic Prophylaxis
11/2018 - 09/2009
5Therapeutics
06/2012 - 05/2007
3Injections
05/2007 - 01/2003
1Transcutaneous Electric Nerve Stimulation (TENS)
11/2007
1Drug Therapy (Chemotherapy)
11/2007
1Aftercare (After-Treatment)
05/2007
1Replantation
10/2005
1Psychology Biofeedback (Biofeedback)
10/2004
1Orchiopexy
07/2003
1Decompression
05/2002
1Prenatal Care (Care, Prenatal)
04/2002